Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Go back to Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
(NYSE: CLDI) Delayed: 1.07 -0.01 (0.93%)
Previous Close $1.08    52 Week High $ 
Open $1.08    52 Week Low $ 
Day High $1.10    P/E N/A 
Day Low $1.05    EPS $ 
Volume 45,793